LLZ
Lv1
70 积分
2024-01-25 加入
-
Insulin glargine versus sitagliptin in insulin-naive patients with type 2 diabetes mellitus uncontrolled on metformin (EASIE): a multicentre, randomised open-label trial
9天前
已关闭
-
Efficacy and safety of sitagliptin monotherapy compared with voglibose in Japanese patients with type 2 diabetes: a randomized, double‐blind trial
10天前
已关闭
-
Efficacy and Safety of Sitagliptin in Patients With Type 2 Diabetes and ESRD Receiving Dialysis: A 54-Week Randomized Trial
11天前
已关闭
-
Efficacy and safety of sitagliptin when added to insulin therapy in patients with type 2 diabetes
12天前
已完结
-
Trastuzumab deruxtecan versus treatment of physician's choice in patients with HER2-positive metastatic breast cancer (DESTINY-Breast02): a randomised, open-label, multicentre, phase 3 trial
18天前
已完结
-
Trastuzumab deruxtecan versus treatment of physician's choice in patients with HER2-positive metastatic breast cancer (DESTINY-Breast02): a randomised, open-label, multicentre, phase 3 trial
18天前
已完结
-
SGLT2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials
20天前
已完结
-
Efficacy and safety of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to metformin for treatment of type 2 diabetes (DURATION-2): a randomised trial
1个月前
已关闭
-
Development and external validation of a machine learning model for prediction of survival in extremity leiomyosarcoma
1个月前
已完结
-
Efficacy and safety of oral semaglutide with flexible dose adjustment versus sitagliptin in type 2 diabetes (PIONEER 7): a multicentre, open-label, randomised, phase 3a trial
1个月前
已完结